Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women

Michelle C. Dimitris, Nandita Perumal, Hayley A. Craig-Barnes, Michael Leadley, Abdullah A. Mahmud, Abdullah Baqui, Daniel E. Roth

Research output: Contribution to journalArticle

Abstract

Vitamin D status is conventionally defined by the serum concentration of 25-hydroxyvitamin D. However, it has been proposed that the serum cholecalciferol concentration (D3) also determines functional vitamin D sufficiency. The objective of this study was to describe the effect of weekly high-dose vitamin D3 supplementation on inter-dose serum D3 in pregnant women. We conducted a sub-study of a completed randomized double-blind placebo-controlled trial of vitamin D3 (35,000 IU/week) supplementation in late pregnancy (AViDD trial) in Dhaka, Bangladesh. This study included pregnant women enrolled at 26-29 weeks gestation who fully adhered to the prenatal supplement intervention for ≥8 consecutive weeks and for whom serum samples were available for D3 analysis (n = 65). Serum D3 was uniformly low at enrolment. Mean D3 increased and was maximal at 1 day after vitamin D dose administration (152.09 nmol/L, SD 25.11 nmol/L) and remained significantly higher in VitD vs. Pl at 7 days (29.59 nmol/L vs. 1.92 nmol/L, p = 0.007). Daily average of the group mean D3 during the week following dosing was 66.97 nmol/L in VitD versus 2.13 nmol/L in Pl. In conclusion, serum D3 remained significantly elevated throughout the week following ≥8 consecutive weekly doses of 35,000 IU D3 in pregnant women. However, the clinically significant minimum threshold of serum D3 remains to be established.

Original languageEnglish (US)
Pages (from-to)76-81
Number of pages6
JournalJournal of Steroid Biochemistry and Molecular Biology
Volume158
DOIs
StatePublished - Apr 1 2016

Fingerprint

Cholecalciferol
Vitamin D
Pregnant Women
Serum
Pregnancy
Bangladesh
Placebos

Keywords

  • Bangladesh
  • Cholecalciferol
  • Pharmacokinetics
  • Pregnancy
  • Vitamin D

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Cell Biology
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Molecular Medicine

Cite this

Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women. / Dimitris, Michelle C.; Perumal, Nandita; Craig-Barnes, Hayley A.; Leadley, Michael; Mahmud, Abdullah A.; Baqui, Abdullah; Roth, Daniel E.

In: Journal of Steroid Biochemistry and Molecular Biology, Vol. 158, 01.04.2016, p. 76-81.

Research output: Contribution to journalArticle

Dimitris, Michelle C. ; Perumal, Nandita ; Craig-Barnes, Hayley A. ; Leadley, Michael ; Mahmud, Abdullah A. ; Baqui, Abdullah ; Roth, Daniel E. / Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women. In: Journal of Steroid Biochemistry and Molecular Biology. 2016 ; Vol. 158. pp. 76-81.
@article{df86410803164b128f9888dafc9f2ad7,
title = "Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women",
abstract = "Vitamin D status is conventionally defined by the serum concentration of 25-hydroxyvitamin D. However, it has been proposed that the serum cholecalciferol concentration (D3) also determines functional vitamin D sufficiency. The objective of this study was to describe the effect of weekly high-dose vitamin D3 supplementation on inter-dose serum D3 in pregnant women. We conducted a sub-study of a completed randomized double-blind placebo-controlled trial of vitamin D3 (35,000 IU/week) supplementation in late pregnancy (AViDD trial) in Dhaka, Bangladesh. This study included pregnant women enrolled at 26-29 weeks gestation who fully adhered to the prenatal supplement intervention for ≥8 consecutive weeks and for whom serum samples were available for D3 analysis (n = 65). Serum D3 was uniformly low at enrolment. Mean D3 increased and was maximal at 1 day after vitamin D dose administration (152.09 nmol/L, SD 25.11 nmol/L) and remained significantly higher in VitD vs. Pl at 7 days (29.59 nmol/L vs. 1.92 nmol/L, p = 0.007). Daily average of the group mean D3 during the week following dosing was 66.97 nmol/L in VitD versus 2.13 nmol/L in Pl. In conclusion, serum D3 remained significantly elevated throughout the week following ≥8 consecutive weekly doses of 35,000 IU D3 in pregnant women. However, the clinically significant minimum threshold of serum D3 remains to be established.",
keywords = "Bangladesh, Cholecalciferol, Pharmacokinetics, Pregnancy, Vitamin D",
author = "Dimitris, {Michelle C.} and Nandita Perumal and Craig-Barnes, {Hayley A.} and Michael Leadley and Mahmud, {Abdullah A.} and Abdullah Baqui and Roth, {Daniel E.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.jsbmb.2016.01.007",
language = "English (US)",
volume = "158",
pages = "76--81",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Effect of weekly high-dose vitamin D3 supplementation on serum cholecalciferol concentrations in pregnant women

AU - Dimitris, Michelle C.

AU - Perumal, Nandita

AU - Craig-Barnes, Hayley A.

AU - Leadley, Michael

AU - Mahmud, Abdullah A.

AU - Baqui, Abdullah

AU - Roth, Daniel E.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Vitamin D status is conventionally defined by the serum concentration of 25-hydroxyvitamin D. However, it has been proposed that the serum cholecalciferol concentration (D3) also determines functional vitamin D sufficiency. The objective of this study was to describe the effect of weekly high-dose vitamin D3 supplementation on inter-dose serum D3 in pregnant women. We conducted a sub-study of a completed randomized double-blind placebo-controlled trial of vitamin D3 (35,000 IU/week) supplementation in late pregnancy (AViDD trial) in Dhaka, Bangladesh. This study included pregnant women enrolled at 26-29 weeks gestation who fully adhered to the prenatal supplement intervention for ≥8 consecutive weeks and for whom serum samples were available for D3 analysis (n = 65). Serum D3 was uniformly low at enrolment. Mean D3 increased and was maximal at 1 day after vitamin D dose administration (152.09 nmol/L, SD 25.11 nmol/L) and remained significantly higher in VitD vs. Pl at 7 days (29.59 nmol/L vs. 1.92 nmol/L, p = 0.007). Daily average of the group mean D3 during the week following dosing was 66.97 nmol/L in VitD versus 2.13 nmol/L in Pl. In conclusion, serum D3 remained significantly elevated throughout the week following ≥8 consecutive weekly doses of 35,000 IU D3 in pregnant women. However, the clinically significant minimum threshold of serum D3 remains to be established.

AB - Vitamin D status is conventionally defined by the serum concentration of 25-hydroxyvitamin D. However, it has been proposed that the serum cholecalciferol concentration (D3) also determines functional vitamin D sufficiency. The objective of this study was to describe the effect of weekly high-dose vitamin D3 supplementation on inter-dose serum D3 in pregnant women. We conducted a sub-study of a completed randomized double-blind placebo-controlled trial of vitamin D3 (35,000 IU/week) supplementation in late pregnancy (AViDD trial) in Dhaka, Bangladesh. This study included pregnant women enrolled at 26-29 weeks gestation who fully adhered to the prenatal supplement intervention for ≥8 consecutive weeks and for whom serum samples were available for D3 analysis (n = 65). Serum D3 was uniformly low at enrolment. Mean D3 increased and was maximal at 1 day after vitamin D dose administration (152.09 nmol/L, SD 25.11 nmol/L) and remained significantly higher in VitD vs. Pl at 7 days (29.59 nmol/L vs. 1.92 nmol/L, p = 0.007). Daily average of the group mean D3 during the week following dosing was 66.97 nmol/L in VitD versus 2.13 nmol/L in Pl. In conclusion, serum D3 remained significantly elevated throughout the week following ≥8 consecutive weekly doses of 35,000 IU D3 in pregnant women. However, the clinically significant minimum threshold of serum D3 remains to be established.

KW - Bangladesh

KW - Cholecalciferol

KW - Pharmacokinetics

KW - Pregnancy

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84960418725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960418725&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2016.01.007

DO - 10.1016/j.jsbmb.2016.01.007

M3 - Article

C2 - 26784272

AN - SCOPUS:84960418725

VL - 158

SP - 76

EP - 81

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

ER -